Tonix Pharmaceuticals (TNXP) Q3 2026 Earnings Call Transcript
TONMYA sales climbed 37% sequentially as payer coverage and sales reach expanded.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Nvidia Stock Slides After Chip Maker Opens Probe
Plus, Dow jumps more than 1,000 points, Nasdaq rallies.
Banxico’s Governor Rodriguez: Considering rate cut since September – El Financiero
The Bank of Mexico (Banxico) Governor Victoria Rodriguez Ceja said in an interview with El Financiero that the Mexican central bank has been considering rate cuts since September.
Skydance Details Cost Savings and Plans HBO Max-Paramount+ Bundle in First Post-Deal Earnings Report
The company says that a streaming bundle will launch early next year, while laying out where it expects to see synergies.
Tokenization platform Securitize gains 10% postmarket on Q3 results, move into asset-backed finance
Securitize saw growth in tokenization last quarter and announced its expansion into asset-backed finance through the acquisition of River One.
Tokenization platform Securitize gains 10% postmarket on Q3 results, move into asset-backed finance
Securitize saw growth in tokenization last quarter and announced its expansion into asset-backed finance through the acquisition of River One.
Why Alphabet Stock Was Moving Higher Today
Alphabet introduced two new chips this morning.
- Alphabet shares rose 1.2% after introducing two new TPUs.
- TPU 8i Max aims to solve memory wall challenge.
- Alphabet sees growth opportunity in AI chips business.